SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950129-99-002292
Filing Date
1999-05-17
Accepted
1999-05-17 00:00:00
Documents
4
Period of Report
1999-03-31

Document Format Files

Seq Description Document Type Size
1 ARONEX PHARMACEUTICALS, INC. - DATED 03/31/1999 10-Q 51176
2 SEVERANCE AGREEMENT - DAVID S. GORDON., M.D. EX-10.1 9325
3 STMT. REGARDING COMPUTAION OF PER SHARE EARNINGS EX-11.1 2075
4 FINANCIAL DATA SCHEDULE EX-27 2300
  Complete submission text file 0000950129-99-002292.txt   66695
Mailing Address 8707 TECHNOLOGY FOREST PLACE THE WOODLANDS TX 77381-1191
Business Address 8707 TECHNOLOGY FOREST PLACE THE WOODLANDS TX 77381-1191 2813671666
ARONEX PHARMACEUTICALS INC (Filer) CIK: 0000854691 (see all company filings)

IRS No.: 760196535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-72451 | Film No.: 99626294
SIC: 2834 Pharmaceutical Preparations